AlphAIalphai — Financial news for AI agents
theglobeandmail.comJUL 293 min read$NICE

RBC Capital Keeps Their Buy Rating on NICE (NICE)

RBC Capital analyst Rishi Jaluria reiterated a Buy rating on NICE on July 26 and set a $130.00 price target. The article cites TipRanks data on Jaluria’s track record. It also notes Rosenblatt kept a Buy on July 21, while Morgan Stanley downgraded NICE to Hold the same day. NICE reported $766.53M revenue and $46.69M net profit for the quarter ended March 31.

Original reporting
theglobeandmail.com
Published Jul 29, 2026, 1:55 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 29, 2026, 3:34 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About alphai AI DeskScoring methodologyReport an issue
RBC Capital Keeps Their Buy Rating on NICE (NICE) — source image
Source · theglobeandmail.com
Decision brief

The 30-second read

$NICENeutralLow
01

Why it matters

This is primarily a sell-side stance update with limited incremental fundamental information; the only quantitative company datapoints are the cited latest quarter revenue and net profit versus the prior year.

02

Market read

Traders may use the reiterated Buy and PT for positioning, but the article lacks new guidance, contract wins, or fresh earnings surprises.

03

What to watch

Conflicting ratings (Rosenblatt Buy vs Morgan Stanley Hold) suggest dispersion; traders may weight the downgrade more than the reiterated target without new guidance or earnings surprises.

Relevance 4/10Novelty 4/10Timing: post-analyst note, after-hours/next-session positioning

Background

The piece centers on RBC Capital’s analyst action on NICE (Buy, $130 PT) and references other recent rating changes.

Company-level read

Ticker impact

$NICENeutralMedium confidence
Context

RBC Capital maintained a Buy on NICE and reiterated a $130 price target, while noting a recent Morgan Stanley downgrade to Hold.

Expected impact

Near-term trading impact likely limited, with sentiment skewing mildly positive due to the reiterated Buy and $130 target.

Evidence & confidence

The newest concrete facts are the reiterated Buy/PT and the mention of a same-day downgrade by Morgan Stanley; no new company fundamentals or guidance are disclosed beyond prior earnings figures.

Market effects

Sector

Read-through to enterprise software/technology analyst sentiment, but no sector-wide new data is provided.

Regional

No specific regional macro or policy catalyst is cited.

Global

No global deal, regulation, or supply-chain event is mentioned.

Counterpoint

What could challenge this read

The reiterated Buy may be less informative if the profitability trend (net profit down vs prior year) is deteriorating, making the $130 target more dependent on assumptions than current results.

Key entities

  • public_company
    NICE

    Enterprise software company discussed as the subject of RBC’s reiterated Buy rating and $130 price target.

  • analyst_firm
    RBC Capital

    Maintained a Buy rating on NICE and set a $130 price target.

  • analyst_firm
    Morgan Stanley

    Downgraded NICE to Hold on the same day referenced in the article.

Read at source← All news

Related articles

AUG 12
$NICEHighAI 9/10

NICE (NICE) Q2 2026 Earnings Call Transcript

NICE Ltd. reported Q2 2026 revenue of $782 million, up 8% year over year, and cloud revenue of $609 million, up 12.6%. Non-GAAP EPS was $2.70. Management cited CX AI and self-service ARR of $362 million (+52%), operating margin of 25.3%, and free cash flow of $93 million. Full-year 2026 revenue guidance is $3.170B to $3.190B.

fool.com7 min
JUL 29
$TEVAMed

Wed: Teva jumps but TASE continues to lose ground

Globes reports the Tel Aviv Stock Exchange fell on July 29, with the Tel Aviv 35 down 0.99% and Tel Aviv 125 down 0.96%. Teva Pharmaceutical (NYSE: TEVA; TASE: TEVA) rose 10.17% after Q2 results and raised revenue guidance. Other movers included Enlight Renewable Energy, Elbit Systems, and banks such as Bank Leumi and Hapoalim.

globes.co.il4 min
JUN 11
$NICEMed

NiCE Announces the Future of AI-Powered CX

NiCE (Nasdaq: NICE) announced that agentic AI is now native at the core of its customer experience platform, enabling enterprises to run AI agents, workflows, data, and systems as a single operating model. The company cited 66% year-over-year growth in first-quarter 2026 annual recurring revenue and said it was 14% of cloud revenue. It also highlighted enterprise security/compliance certifications and cited customer and analyst recognition.

itwire.com3 min
JUN 3
$SOUNMedAI 8/10

SoundHound AI (NASDAQ: SOUN) Bets On Proprietary AI Models To Outpace NICE (NASDAQ: NICE) And Five9 (NASDAQ: FIVN)

SoundHound AI (SOUN) says it is shifting toward proprietary AI models to compete in conversational and agentic AI. It launched OASYS, which management says can create, orchestrate, evaluate and improve agents and cut deployment from months to minutes. SoundHound plans to use its Polaris speech model and internal LLMs to reduce reliance on costly third-party models. It reported Q1 2026 revenue of $44.2M (+52% YoY). The article notes SOUN trades at 16x forward P/S vs 13.48 industry average and has

foreignpolicyjournal.com5 min
JUN 1
$TSEMMed

Mon: TASE suffers biggest falls since October 8, 2023

Israel’s Tel Aviv Stock Exchange fell sharply after Iran halted talks with the US over escalation in Lebanon, according to the report. The Tel Aviv 35 Index dropped 4.21% to 4,268.02 and Tel Aviv 125 fell 4.31% to 4,239.39. Turnover was NIS 5.91b in equities and NIS 6.31b in bonds. Tower Semiconductor led losses (-13.99%).

en.globes.co.il3 min